Tetrahydrocarbazole-6-sulfonamides represent a versatile scaffold for selective inhibition of NOX2 and NOX4, with ASP5 and ASP20 identified as promising leads for targeting NOX-mediated oxidative stress in TBI.
Pathania et al. (Thu,) studied this question.